The Diagnostic Imaging mammography modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of mammography, including 2D digital mammography, digital breast tomosynthesis, and breast ultrasound.
April 17th 2025
Seniors who had at least one prior screening mammography exam in the five years prior to breast cancer diagnosis were over a third less likely to die from breast cancer, according to new research.
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
43rd Annual Miami Breast Cancer Conference®
March 5-8, 2026
Register Now!
19th Annual New York GU Cancers Congress™
March 13-14, 2026
Register Now!
Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies
View More
(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice
View More
Hologic revenues boom but stock price dives
May 1st 2007Earnings rose at Hologic in the second fiscal quarter of 2007 and the company raised its guidance for the year, leading to a heady market open for traders in the company’s stock. But shares failed to follow through, and the stock plummeted from a height of $60 to within a few cents of $53 within a half hour. The ride continued as shares traded up and down throughout the morning, settling in a range between $54 and $56 by midday.
Why the NEJM study on CAD is wrong
April 6th 2007Next year, my son will begin driving the family car. Before he does, he’ll learn the rules of the road in a classroom and behind the wheel, not to mention undergoing the umpteen hours of driving I have planned for the two of us in parking lots and on side roads. Yet I know that teenagers, though just 7% of licensed drivers, suffer 14% of fatalities and 20% of all reported accidents. How do I know? Because statisticians have told me.
Hologic execs assail CAD study as flawed
April 5th 2007A study asserting that mammography CAD does more harm than good is deeply flawed in design and conclusions, according to executives at Hologic. The study, which appears today in The New England Journal of Medicine, concludes that CAD, when used in screening mammography, causes significantly more callbacks and biopsies without increased cancer detection.
Imagers prove too hasty in dismissing breast CAD
April 1st 2007Radiologists may be adept at rejecting hundreds of false positives flagged by computer-aided detection software, but they also have a strong tendency to dismiss correctly identified cancers, mistakenly believing the findings are benign, according to new research.
Big pharma sways breast cancer research
April 1st 2007For the first time, data accrued over a decade show that the involvement of the pharmaceutical industry in clinical breast cancer research may have significantly influenced study design, focus, and results, according to a study published in the April 1 issue of Cancer.
Computer-aided detection proves useful in lung x-rays
April 1st 2007Radiologists can maximize their diagnoses of lung abnormalities using computer-aided detection systems if they develop a better understanding of the strengths and shortcomings of every factor involved in the process, according to studies presented at the RSNA meeting.
Quality issue must move beyond mammography
March 26th 2007Trails blazed in medicine often bring controversy and even consternation. Breast care is no different. Since 1965, when the American College of Radiology formed the Committee on Mammography, advances in breast imaging and legislation to ensure its quality have largely centered on x-ray mammography.
Screening mammography travels back roads of Europe
March 15th 2007GE Healthcare is refining its mobile approach to screening mammography in outreach efforts aimed at serving Europe’s diverse populations, adapting digital technology to meet the rural challenges found in both Western and Eastern European nations.
Breast specialists emphasize functional, physical, and chemical aspects of imaging
March 12th 2007The dominance of x-ray mammography in breast screening seems unlikely to change before ECR 2008, or even ECR 2018. But when it comes to clarifying a positive read or assessing the cause of symptomatic breast pain, a whole host of alternative diagnostic approaches are waiting in the wings.
CAD technology cools its heels amid skepticism
March 12th 2007Does software that flags malignancies on medical images help, hinder, or make no difference to patient management? That question has dogged radiology for years. Automated detection systems are undoubtedly becoming smarter, strengthening arguments for their use. But no system is perfect, and doubts remain, leading to a widespread policy of wait and see.
Compression shrinks digital mammograms down to practical size
March 9th 2007Wavelet compression can shrink large, unwieldy digital mammography images by a factor of 100 without any loss in image quality, according to a German study presented at the ECR. This finding has tremendous potential benefits for productivity, transmission speed for teleradiology, and PACS storage costs.
Report from ECR: New president and forward-looking scientific program reflect youth movement
March 8th 2007Youth will rise to the fore at today's European Congress of Radiology. At just 51 years of age, Prof. Christian Herold is one of the youngest ECR presidents and the first from Austria. He admits that he represents the new generation of leaders.
Big pharma sways breast cancer research
February 27th 2007For the first time, data accrued over a decade show that the involvement of the pharmaceutical industry in clinical breast cancer research may have significantly influenced study design, focus, and results, according to a study published in the April 1 issue of Cancer.
Automated breast US nears clinical acceptance
February 1st 2007Breast ultrasound is a highly useful tool in the hands of an expert, but it is notoriously operator-dependent. Systems that offer partial or full automation to minimize performance variability are gaining attention, as trial data accumulate and system designs evolve.
Breast cancer recurrence proves common in uncommon male patients
February 1st 2007Men treated for breast cancer face a significantly high risk of future cancers, according to a study published online in the January issue of Breast Cancer Research. The data validate previous findings and suggest a role for screening in these patients.
New management brings acoustical holography to market
January 2nd 2007The thrust for Richland, WA-based Advanced Imaging Technologies over the last four years has been to transform the acoustical holography system developed by its predecessor firm, Advanced Diagnostics, into a commercial product. The fruit of those labors is the company’s first product, its Aria Breast Imaging System.